# Hims and Hers to offer unapproved peptides after US eases curbs

- HackerByte page: <https://hackerbyte.net/en/stories/a-company-s-decision-to-offer-unapproved-drugs-following-changes-in-health-regul-50437357>
- Original source: <https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-narrows-2026-revenue-forecast-margins-contract-2026-11-09/>
- Hacker News discussion: <https://news.ycombinator.com/item?id=50437357>
- Submitted to Hacker News: 2026-11-10T07:56:31.000Z

A company's decision to offer unapproved drugs following changes in health regulations.

## AI-generated summary

No summary is available in this language yet.